This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
CORE-001
CS-003
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Decipher Genomic Classifier
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
Masofaniten (EPI-7386)
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
BCAN TT 2024
SNMMI 2024
AMA 2024
ASCO 2024
AUA 2024
All Conferences
View All
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Is Abiraterone Acetate Well Tolerated and Effective in the Treatment of Castration-Resistant Prostate Cancer? - Abstract
November 7, 2008
Metabolic and Cardiovascular Effects of Androgen Deprivation Therapy - Abstract
September 8, 2008
ASCO 2008 Annual Meeting - Updated Analysis of a Phase II Study Using Sorafenib (S) for Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
August 22, 2008
ASCO 2008 Annual Meeting - Phase II Trial of Thalidomide (T), Bevacizumab (Bv), and Docetaxel (Doc) in Patients (pts) with Metastatic Castration-Refractory Prostate Cancer (mCRPC)
August 21, 2008
ASCO 2008 Annual Meeting - Phase I Trial of Ipilimumab (IPI) Alone and in Combination with Radiotherapy (XRT) in Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
August 19, 2008
ASCO 2008 Annual Meeting - Identification of an Androgen Withdrawal Responsive Phenotype in Castrate Resistant Prostate Cancer (CRPC) Patients (pts) Treated with Abiraterone Acetate (AA)
August 13, 2008
ASCO 2008 Annual Meeting - Crossover Pharmacokinetics (PK) Study to Assess Oral Administration of Abiraterone Acetate Capsule and Tablet Formulations in Fasted and Fed States in Patients with Prostate Cancer
August 13, 2008
ASCO 2008 Annual Meeting - Anti-Tumor Activity of Abiraterone Acetate (AA), a CYP17 Inhibitor of Androgen Synthesis, in Chemotherapy Naive and Docetaxel Pre-Treated Castration Resistant Prostate Cancer (CRPC)
August 13, 2008
ASCO 2008 Annual Meeting - Abiraterone Acetate and Prednisone in Patients (Pts) with Progressive Metastatic Castration Resistant Prostate Cancer (CRPC) After Failure of Docetaxel-Based Chemotherapy
August 13, 2008
The influence of developmental life stage on quality of life in survivors of prostate cancer and their partners - Abstract
July 1, 2008
The Ultrastructure of Detrusor in Patients with Benign Prostatic Hyperplasia
June 24, 2008
Is seeing a specialist nurse associated with positive experiences of care? The role and value of specialist nurses in prostate cancer care - Abstract
April 11, 2008
GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy
February 15, 2008
GU Cancers Symposium - ASCO ASTRO SUO - 2008 - Preliminary Phase II Results of Abiraterone Acetate in Patients with Castration-resistant metastatic Prostate Cancer after Failure of Docetaxel-based Chemotherapy
February 15, 2008
Redefining Clinically Significant Castration Levels in Patients with Prostate Cancer Receiving Continuous Androgen Deprivation Therapy
September 20, 2007
Statin Drugs and Risk of Advanced Prostate Cancer
March 6, 2007
Page 1413 of 1413
Start
Prev
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free